Cargando…
MiR-378a inhibits glucose metabolism by suppressing GLUT1 in prostate cancer
Prostate cancer (PCa) is the fifth leading cause of cancer related deaths worldwide, in part due to a lack of molecular stratification tools that can distinguish primary tumours that will remain indolent from those that will metastasise. Amongst potential molecular biomarkers, microRNAs (miRs) have...
Autores principales: | Cannistraci, A., Hascoet, P., Ali, A., Mundra, P., Clarke, N. W., Pavet, V., Marais, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897193/ https://www.ncbi.nlm.nih.gov/pubmed/35039635 http://dx.doi.org/10.1038/s41388-022-02178-0 |
Ejemplares similares
-
Depicting the Implication of miR-378a in Cancers
por: Qin, Yuelan, et al.
Publicado: (2022) -
The Role of miR-378a in Metabolism, Angiogenesis, and Muscle Biology
por: Krist, Bart, et al.
Publicado: (2015) -
Upregulated miR‑378a‑3p expression suppresses energy metabolism and promotes apoptosis by targeting a GLUT‑1/ALDOA/PKM2 axis in esophageal carcinoma
por: Qu, Yuan, et al.
Publicado: (2023) -
miR-378d suppresses malignant phenotype of ESCC cells through AKT signaling
por: Peng, Jie, et al.
Publicado: (2021) -
Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma
por: Redova, Martina, et al.
Publicado: (2012)